Sinane M, et al. (2024) Potential of Marine Sponge Metabolites against Prions: Bromotyrosine Derivatives, a Family of Interest. Mar Drugs 22(10) PMID:39452864
Conan P, et al. (2022) New insights into the regulation of Cystathionine beta synthase (CBS), an enzyme involved in intellectual deficiency in Down syndrome. Front Neurosci 16:1110163 PMID:36711154
Ganapathi M, et al. (2022) A homozygous splice variant in ATP5PO, disrupts mitochondrial complex V function and causes Leigh syndrome in two unrelated families. J Inherit Metab Dis 45(5):996-1012 PMID:35621276
Lista MJ, et al. (2017) Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA. Nat Commun 8:16043 PMID:28685753
Lista MJ, et al. (2017) A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness. Microb Cell 4(9):305-307 PMID:28913345
Lista MJ, et al. (2015) The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus. Biotechnol J 10(11):1670-81 PMID:26311489
Nguyen P, et al. (2014) Evaluation of the antiprion activity of 6-aminophenanthridines and related heterocycles. Eur J Med Chem 82:363-71 PMID:24927056
Voisset C and Blondel M (2014) [Chemobiology at happy hour: yeast as a model for pharmacological screening]. Med Sci (Paris) 30(12):1161-8 PMID:25537047
Voisset C, et al. (2014) Using yeast to model calcium-related diseases: example of the Hailey-Hailey disease. Biochim Biophys Acta 1843(10):2315-21 PMID:24583118
Pang Y, et al. (2013) The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition. J Biol Chem 288(26):19081-9 PMID:23673663
Voisset C, et al. (2009) Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models. Infect Disord Drug Targets 9(1):31-9 PMID:19200013